Project Details
Description
MEK114267, A Phase III Randomized, Open-Label Study Comparing GSK1120212 to Chemotherapy in Subjects with Advanced or Metastatic BRAF V600E/K Mutation Positive Melanoma
| Status | Finished |
|---|---|
| Effective start/end date | 9/28/10 → 10/30/12 |
Funding
- GLAXOSMITHKLINE
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.